SCHEMBL5804022

SCHEMBL5804022

CCN(CC)c1ncc(N(S(C)(=O)=O)S(=O)(=O)c2ccc(Cl)cc2)c(N[C@@H](Cc2ccc(OC(=O)N3CCC3)cc2)C(=O)O)n1

nearest known ligand 0.74

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 20/20 0.74
ITGA4 P13612 20/20 0.74
ITGB7 P26010 20/20 0.74
ITGAV P06756 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2957798 0.92 ITGB1 (0.78) ITGB1ITGA4ITGB7ITGAV
SCHEMBL2957040 0.92 ITGB1 (0.78) ITGB1ITGA4ITGB7ITGAV
SCHEMBL13671316 0.90 ITGB1 (0.80) ITGB1ITGA4ITGB7ITGAV
SCHEMBL2926949 0.90 ITGB1 (0.80) ITGB1ITGA4ITGB7ITGAV
SCHEMBL2962382 0.90 ITGB1 (0.80) ITGB1ITGA4ITGB7ITGAV
Hydrochloric Acid SCHEMBL2961791 0.90 ITGB1 (0.79) ITGB1ITGA4ITGB7ITGAV
SCHEMBL2951232 0.87 ITGB1 (0.88) ITGB1ITGA4ITGB7ITGAV
SCHEMBL2846116 0.85 ITGB1 (1.00) ITGB1ITGA4ITGB7
SCHEMBL2846069 0.85 ITGB1 (1.00) ITGB1ITGA4ITGB7
SCHEMBL2959524 0.85 ITGB1 (0.79) ITGB1ITGA4ITGB7ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1507775-A4 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY ALPHA4 INTEGRINS ELAN PHARM INC (US) 2006-05-24 EP disclosed
EP-1507775-A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY ALPHA4 INTEGRINS Elan Pharmaceuticals, Inc. (US) 2005-02-23 EP disclosed
WO-2003099809-A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY α4 INTEGRINS ELAN PHARMACEUTICALS, INC. (US) 2003-12-04 WO disclosed